Model
Edge
Alnylam Pharmaceuticals, Inc.
0001661908
Filing Type
4
Filing Date
5/19/2024
Updated
5/20/24, 2:08 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership